Editor's Picks
Editor's Picks
Today’s Top Stock Gainers: Short Squeezes, Biotech Surges, and Defense Tech Expansion
July 27, 2026AstraZeneca (NYSE: AZN) Q2 Earnings Soar Amidst Generic Competition
July 27, 2026AstraZeneca (NYSE: AZN)‘s core earnings per share (EPS) of $2.63 significantly surpassed analyst estimates of $2.50, marking a 21% increase year-over-year. AstraZeneca’s total revenue reached $15.38 billion, a 6% rise...
Editor's Picks
We will not share your information & you can unsubscribe at any time. You agree to our terms of service & privacy policy. You agree to receive emails & correspondence from Nextmemealert.
